The NHS has begun a mass rollout of weight loss jabs in England, with GPs allowed to prescribe the medicine for the first time. Over the next 12 years through NHS primary care providers, 1.6 million people are expected to receive tirzepatide,

Around 220,000 people with "greatest need" are expected to receive Mounjaro, also known as tirzepatide and made by Lilly through the NHS over the next three years

GPs will be allowed to prescribe weight loss jabs for the first time from Monday. The mass rollout will see around 220,000 people with the ‘greatest need’ receive Mounjaro, also known as tirzepatide,